Latest News by Industry
PLYMOUTH MEETING, Pa. (AP) _ Inovio Pharmaceuticals Inc. (INO) on Tuesday reported a loss of $37.8 million in its third quarter.
The Plymouth Meeting, Pennsylvania-based company said it had a loss of 15 cents per share.
The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 29 cents per share.
The drugmaker posted revenue of $9.2 million in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a INO">Zacks stock report on INO at https://www.zacks.com/ap/INO